{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:25:56Z","timestamp":1790699156546,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Allergy Therapeutics"}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.waojou.2019.100087","type":"journal-article","created":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T11:27:43Z","timestamp":1573903663000},"page":"100087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Transcriptome analysis and safety profile of the early-phase clinical response to an adjuvanted grass allergoid immunotherapy"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4914-4051","authenticated-orcid":false,"given":"Sviatlana","family":"Starchenka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyson","family":"Lineberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Higenbottam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray A.","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.waojou.2019.100087_bib1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1034\/j.1398-9995.2000.00526.x","article-title":"Consensus statement on the treatment of allergic rhinitis. European academy of allergology and clinical immunology","volume":"55","author":"van Cauwenberge","year":"2000","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2019.100087_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2500\/aap.2011.32.3453","article-title":"Ultra-short-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen","volume":"32","author":"DuBuske","year":"2011","journal-title":"Allergy Asthma Proc"},{"issue":"7","key":"10.1016\/j.waojou.2019.100087_bib3","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.4161\/hv.24631","article-title":"Pollinex Quattro: an innovative four injections immunotherapy in allergic rhinitis","volume":"9","author":"Rosewich","year":"2013","journal-title":"Hum Vaccines Immunother"},{"issue":"2","key":"10.1016\/j.waojou.2019.100087_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0301-0546(03)79172-1","article-title":"Single-course specific immunotherapy with mixed pollen allergoids: results of a multi-centre study","volume":"31","author":"Drachenberg","year":"2003","journal-title":"Allergol Immunopathol"},{"key":"10.1016\/j.waojou.2019.100087_bib5","author":"Muraro","year":"2017"},{"issue":"10","key":"10.1016\/j.waojou.2019.100087_bib6","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1398-9995.2011.02669.x","article-title":"PA et\u00a0al. European Academy and Clinical Immunology task force report on 'dose-response relationship in allergen-specific immunotherapy","volume":"66","author":"Calderon","year":"2011","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.waojou.2019.100087_bib7","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jaci.2007.07.046","article-title":"Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis","volume":"120","author":"Didier","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2019.100087_bib8","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jaci.2005.12.1358","article-title":"Sublingual immunotherapy with once-daily grass allergen tablets: a randomised controlled trial in seasonal allergic rhinoconjunctivitis","volume":"117","author":"Durham","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2019.100087_bib9","first-page":"99","article-title":"Development of a sublingual allergy vaccine for grass pollinosis","volume":"4","author":"Frati","year":"2010","journal-title":"Drug Des Dev Ther"},{"issue":"11","key":"10.1016\/j.waojou.2019.100087_bib10","doi-asserted-by":"crossref","first-page":"100075","DOI":"10.1016\/j.waojou.2019.100075","article-title":"Strong dose response after immunotherapy with PQ Grass using conjunctival provocation test","volume":"12","author":"Zielen","year":"2019","journal-title":"World Allergy Organ J"},{"issue":"1","key":"10.1016\/j.waojou.2019.100087_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40413-017-0146-3","article-title":"Molecular fingerprinting of complex grass allergoids: size assessments reveal new insights in epitope repertoires and functional capacities","volume":"10","author":"Starchenka","year":"2017","journal-title":"World Allergy Organ J"},{"issue":"9","key":"10.1016\/j.waojou.2019.100087_bib12","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.4049\/jimmunol.1800035","article-title":"Microcrystalline tyrosine and aluminum as adjuvants in allergen-specific immunotherapy protect from IgE-mediated reactivity in mouse models and act independently of inflammasome and TLR signaling","volume":"200","author":"Leuthard","year":"2018","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.waojou.2019.100087_bib13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jinorgbio.2015.08.007","article-title":"The adsorption of allergoids and 3-O-desacyl-4\u2032-monophosphoryl lipid A (MPL\u00ae) to microcrystalline tyrosine (MCT) in formulations for use in allergy immunotherapy","volume":"152","author":"Bell","year":"2015","journal-title":"J\u00a0Inorg Biochem"},{"issue":"6","key":"10.1016\/j.waojou.2019.100087_bib14","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/1744666X.2017.1292133","article-title":"Clinical use of adjuvants in allergen-immunotherapy","volume":"13","author":"Klimek","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2019.100087_bib15","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000321826","article-title":"Sublingual allergen-specific immunotherapy adjuvanted with monophosphoryl lipid A: a phase I\/IIa study","volume":"154","author":"Pfaar","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"issue":"7","key":"10.1016\/j.waojou.2019.100087_bib16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2217\/imt-2018-0004","article-title":"Long-term effect of monophosphoryl lipid A adjuvanted specific immunotherapy in patients with grass pollen allergy","volume":"10","author":"Zielen","year":"2018","journal-title":"Immunotherapy"},{"issue":"5","key":"10.1016\/j.waojou.2019.100087_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40629-017-0029-8","article-title":"Long-term efficacy of specific subcutaneous, short-term MPL adjuvant immunotherapy over three treatment and three follow-up years, as measured by quality of life","volume":"26","author":"Rabe","year":"2017","journal-title":"Allergo J Int"},{"issue":"5","key":"10.1016\/j.waojou.2019.100087_bib18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0301-0546(03)79195-2","article-title":"Efficacy and tolerability of short-term specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A (MPL\u00ae) for children and adolescents","volume":"31","author":"Drachenberg","year":"2003","journal-title":"Allergol Immunopathol"},{"issue":"1","key":"10.1016\/j.waojou.2019.100087_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/all.12890","article-title":"Allergen-specific immunotherapy: is it vaccination against toxins after all?","volume":"72","author":"Bachmann","year":"2017","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.waojou.2019.100087_bib20","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jaci.2013.01.049","article-title":"Update on allergy immunotherapy: American academy of allergy, asthma & immunology\/european academy of allergy and clinical immunology\/PRACTALL consensus report","volume":"131","author":"Burks","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.waojou.2019.100087_bib21","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/all.13138","article-title":"Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper","volume":"72","author":"Shamji","year":"2017","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.waojou.2019.100087_bib22","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/all.13135","article-title":"Novel approaches and perspectives in allergen immunotherapy","volume":"72","author":"Hoffmann","year":"2017","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.waojou.2019.100087_bib23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in ingenuity pathway analysis","volume":"30","author":"Kr\u00e4mer","year":"2013","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.waojou.2019.100087_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/1753465816669662","article-title":"Applications and mechanisms of immunotherapy in allergic rhinitis and asthma","volume":"11","author":"Kappen","year":"2017","journal-title":"Ther Adv Respir Dis"},{"issue":"1","key":"10.1016\/j.waojou.2019.100087_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1476-7961-9-12","article-title":"Early gene expression changes with rush immunotherapy\u201d","volume":"9","author":"Davis","year":"2011","journal-title":"Clin Mol Allergy"},{"issue":"5","key":"10.1016\/j.waojou.2019.100087_bib26","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1128\/IAI.71.5.2498-2507.2003","article-title":"Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A","volume":"71","author":"Martin","year":"2003","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.waojou.2019.100087_bib27","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1398-9995.2005.00762.x","article-title":"Monophosphoryl lipid A (MPL\u00ae)* promotes allergen-induced immune deviation in favour of Th1 responses","volume":"60","author":"Puggioni","year":"2005","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.waojou.2019.100087_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T\u00a0cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.waojou.2019.100087_bib29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jaci.2015.09.015","article-title":"Changes in markers associated with dendritic cells driving the differentiation of either TH2 cells or regulatory T cells correlate with clinical benefit during allergen immunotherapy","volume":"137","author":"Gueguen","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2019.100087_bib30","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jaci.2012.02.014","article-title":"A\u00a0regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy","volume":"129","author":"Zimmer","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2019.100087_bib31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jaci.2015.10.047","article-title":"Innate mechanisms can predict successful allergy immunotherapy","volume":"137","author":"O'mahony","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2019.100087_bib32","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jaci.2017.10.010","article-title":"Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers","volume":"140","author":"Shamji","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2019.100087_bib33","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.4049\/jimmunol.0901379","article-title":"Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation","volume":"184","author":"M\u00f6bs","year":"2010","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2019.100087_bib34","first-page":"1","article-title":"Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens","volume":"8","author":"Akdis","year":"2015","journal-title":"World Allergy Organ J"},{"issue":"6","key":"10.1016\/j.waojou.2019.100087_bib35","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/all.12608","article-title":"Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge","volume":"70","author":"Scadding","year":"2015","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.waojou.2019.100087_bib36","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.jaci.2017.09.041","article-title":"Synchronous immune alterations mirror clinical response during allergen immunotherapy","volume":"141","author":"Renand","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2019.100087_bib37","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.imbio.2010.11.002","article-title":"Transcriptional regulation of Foxp3 in regulatory T cells","volume":"216","author":"Haiqi","year":"2011","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.waojou.2019.100087_bib38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/08830185.2013.863303","article-title":"Forkhead box P3: the peacekeeper of the immune system","volume":"33","author":"Passerini","year":"2014","journal-title":"Int Rev Immunol"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455119312438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455119312438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:41:19Z","timestamp":1761849679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455119312438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1939455119312438"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2019.100087","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcriptome analysis and safety profile of the early-phase clinical response to an adjuvanted grass allergoid immunotherapy","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2019.100087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100087"}}